ロード中...
Functional characterization of reappearing B cells after anti-CD20 treatment of CNS autoimmune disease
The anti-CD20 antibody ocrelizumab, approved for treatment of multiple sclerosis, leads to rapid elimination of B cells from the blood. The extent of B cell depletion and kinetics of their recovery in different immune compartments is largely unknown. Here, we studied how anti-CD20 treatment influenc...
保存先:
| 出版年: | Proc Natl Acad Sci U S A |
|---|---|
| 主要な著者: | , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
National Academy of Sciences
2018
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6166805/ https://ncbi.nlm.nih.gov/pubmed/30194232 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1073/pnas.1810470115 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|